Cognate Insights

[null]

Media Inquiries

Cognate’s team is available to discuss our recent news further.

Contact

BMWS20

Cognate is a proud sponsor of the 2020 Biomanufacturing World Summit.  Click the button below to schedule a meeting with the Cognate team to learn how your organization can be... Read More

Best Practices in Inter-laboratory transfer of analytical methods

Overview Working at a leading CDMO as a Director of Innovative solutions and senior scientist, I have been involved in assay development, validation, and transfer of innovative... Read More

Cognate BioServices Names Tom Pamukcoglu as VP, Global Head of Quality

MEMPHIS, Tennessee, November 2, 2020 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, announced today the... Read More

WEBINAR: Best Practices for Analytical Method Transfer for Cell Therapy Products

Read More

J. Kelly Ganjei to speak at the Morgan Stanley Global Healthcare Conference

Join Cognate's CEO, J. Kelly Ganjei, as he speaks at the upcoming Morgan Stanley Global Healthcare Conference - Thursday, September 17 at 2:45pm EDT.  ... Read More

J. Kelly Ganjei of Cognate announced as an Entrepreneur Of The Year® 2020 Southeast Award Finalist

Ernst & Young LLP (EY US) today announced that J. Kelly Ganjei, CEO of Cognate BioServices, Inc. was named an Entrepreneur Of The Year® 2020 Southeast Award finalist. Now in... Read More

Cognate Announces the Appointment of Two Independent Board Members

MEMPHIS, Tennessee, August 20, 2020/PRNewswire/ -- Cognate BioServices, Inc. announced today the appointments of Timothy Moore and Steven Kasok as independent non-executive... Read More

Cognate Reveals New Brand Identity with Redesigned Logo and Website

  Read More

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics

MEMPHIS, Tenn., January 21, 2019 /PRNewswire/ — Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated... Read More

Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

Providing large scale manufacturing capacity for AZD1222 KEELE, United Kingdom, June 16, 2020 /PRNewswire/ — Cobra Biologics (Cobra), part of the Cognate BioServices family,... Read More
No More Posts